AI assistant
ADVFN PLC Remuneration Information 2020
7468_def-14a_2020-12-30_529ee546-6b95-41eb-b97f-64c53dd92e3b.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 1668K
ADVFN PLC
30 December 2020
For immediate release
30 December 2020
ADVFN PLC
("ADVFN" or the "Company")
Director / PDMR shareholding
The Board of ADVFN PLC announces that the Board has agreed to amend the terms of 1,222,946 options held by certain directors, in aggregate representing 4.76 per cent. of the issued share capital of the Company. The exercise price of the options has been re-set at 14p per new ordinary share (compared to a closing mid-market price of 11.5p on 29 December 2020). Prior to the amendment, the options had exercise prices substantially greater than the prevailing market price.
The table below sets out the amended options:
| Director | ||||||
| Original grant date | M Hodges | C Chambers | J Mullins | M Collom | Pre-amendment exercise price per share | Amended exercise price per share |
| 27.01.04 | 40,000 | 60,000 | 40,000 | 0 | 118.75p | 14p |
| 27.01.05 | 40,000 | 60,000 | 40,000 | 0 | 115p | 14p |
| 06.09.06 | 60,000 | 60,000 | 60,000 | 0 | 82.5p | 14p |
| 21.10.09 | 31,473 | 31,473 | 0 | 0 | 76.4p | 14p |
| 12.12.14 | 200,000 | 200,000 | 100,000 | 200,000 | 79.5p | 14p |
The re-setting of the option exercise price was reviewed by the independent non-executive director of the Company, Mr Tom Spiller and approved on 29 December 2020. Other than an amendment to the exercise price, the terms of the options remain unaltered. Other than the options granted in 2014 (which lapse on 12 December 2024), the options set out in the table above will lapse unless exercised on or before 31 December 2022. No other options have been issued or amended in the prior 12-month period.
A copy of this announcement is available on the Company's website, at www.advfn.com
For further information please contact:
| ADVFN PLC Clem Chambers CEO Tel: +44 20 3868 6702 |
| Beaumont Cornish Limited (Nominated Adviser) www.beaumontcornish.com |
| Roland Cornish/Michael Cornish Tel: +44 (0) 207 628 3396 |
| Cassiopeia Ltd (Investor Relations) Stefania Barbaglio |
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1. Michael Hodges
2. Clem Chambers
3. Jonathan Mullins
4. Matthew Collom
2
Reason for the notification
a)
Position/
status
1. Chairman
2. Chief Executive
3. Director
4. Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ADVFN plc
b)
LEI
21380042SDV1E1ZVIY40
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Options over Ordinary Shares of 0.2p each ("Ordinary Shares")
Identification code
GB00BPT24C10
b)
Nature of the transaction
Amendment of exercise price of options over Ordinary Shares
c)
Price(s) and volume(s)
| Director | Price payable on exercise of option | Volume(s) |
| Michael Hodges | £0.14 | 371,473 |
| Clem Chambers | £0.14 | 411,473 |
| Jonathan Mullins | £0.14 | 240,000 |
| Matthew Collom | £0.14 | 200,000 |
d)
Aggregated information
- Aggregated volume
1,222,946 options over Ordinary Shares
- Price
Price payable on exercise of option - UK£0.14
e)
Date of the transaction
29 December 2020
f)
Place of the transaction
Outside a trading venue
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHLBLFXBLLFFBK